Pfizer Inc. (NYSE:PFE) recently released encouraging top-line results from a randomized, placebo-controlled trial, CAPiTA (Community-Acquired Pneumonia Immunization Trial in Adults) on pneumonia vaccine Prevenar 13. Pfizer Inc. (NYSE:PFE) stock opened at $31.55 in last session, and closed at $31.89, while the day range of stock is $31.54 – $31.99. The stock showed a positive weekly performance of 0.03%.
Merck & Co (NYSE:MRK) announced a quarterly dividend on Tuesday, February 25th, StockRatingsNetwork reports. Stockholders of record on Monday, March 17th will be paid a dividend of 0.44 per share on Monday, April 7th. Merck & Co., Inc. (NYSE:MRK) stock opened at $56.13, in last session and closed at $55.91, by losing -0.48%. The 52 week range of the stock is $42.10 – $56.92. Company’s market capitalization is $163.63 billion.
Bristol-Myers Squibb (NYSE:BMY) was downgraded by analysts at Edward Jones from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday, Analyst Ratings Network reports. Bristol-Myers Squibb Co (NYSE:BMY) stock decreased -1.16% and finished the last session at $53.68. The EPS of the stock remained 1.55. Company’s market capitalization is $88.58 billion.
Eli Lilly & Co (NYSE:LLY)’s experimental drug dulaglutide was as good at controlling Type 2 diabetes as the leading treatment in a clinical trial, providing Lilly with a potential marketing advantage as it seeks to gain approval of the medicine. Eli Lilly and Co (NYSE:LLY) stock opened the session at $57.99, and closed the session at $58.48. The 52 week range of the stock remained $47.53 – $58.90 and the day range was $57.93 – $58.84.